Taurine modulates catalytic activity of cytochrome P450 3A4

被引:0
|
作者
V. V. Shumyantseva
A. A. Makhova
T. V. Bulko
R. Bernhardt
A. V. Kuzikov
E. V. Shich
V. G. Kukes
A. I. Archakov
机构
[1] Orekhovich Institute of Biomedical Chemistry,Institute for Biochemistry
[2] Sechenov First Moscow State Medical University,undefined
[3] Saarland University,undefined
来源
Biochemistry (Moscow) | 2015年 / 80卷
关键词
cytochrome P450; antioxidants; drug metabolism; bioelectrochemistry; taurine;
D O I
暂无
中图分类号
学科分类号
摘要
The influence of the biologically active compound taurine on the stability and catalytic properties of the hemoprotein cytochrome P450 3A4 has been investigated. The catalytic properties were analyzed by electrochemical methods (cyclic and square-wave voltammetry) using cytochrome P450 3A4 immobilized on the electrode. Taurine at concentrations in the range 10–70 μM stimulated the electrochemical reduction of cytochrome P450 3A4, and the reduction was the highest (115 ± 3%) in the presence of 50 μM taurine. Taurine pronouncedly attenuated the itraconazol-caused inhibition of the P450 isoenzyme P450 3A4. Taurine protected cytochrome P450 3A4 due to stabilizing it during electrolysis at controlled voltage in the presence of erythromycin as a substrate. This protection was manifested by an increase in the amount of the “residual” reduced form of the hemoprotein (52 ± 5 and 71 ± 8%, respectively).
引用
收藏
页码:366 / 373
页数:7
相关论文
共 50 条
  • [31] Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice
    Qin, Chong-Zhen
    Lv, Qiao-Li
    Wu, Na-Yiyuan
    Cheng, Lin
    Chu, Yun-Chen
    Chu, Tang-Yuan
    Hu, Lei
    Cheng, Yu
    Zhang, Xue
    Zhou, Hong-Hao
    JOURNAL OF ETHNOPHARMACOLOGY, 2015, 168 : 146 - 149
  • [32] Kinetics of electron transfer between NADPH-cytochrome P450 reductase and cytochrome P450 3A4
    Farooq, Yassar
    Roberts, Gordon C. K.
    BIOCHEMICAL JOURNAL, 2010, 432 : 485 - 493
  • [33] Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4
    Isin, EM
    Guengerich, FP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (14) : 9127 - 9136
  • [34] Anthocyanins and their metabolites are weak inhibitors of cytochrome P450 3A4
    Dreiseitel, Andrea
    Schreier, Peter
    Oehme, Anett
    Locher, Sanja
    Hajak, Goeran
    Sand, Philipp G.
    MOLECULAR NUTRITION & FOOD RESEARCH, 2008, 52 (12) : 1428 - 1433
  • [35] Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
    Bottorff, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (08): : 1042 - 1043
  • [36] Regioselectivity preference of testosterone hydroxylation by cytochrome P450 3A4
    Yan Zhang
    Phani Morisetti
    Jeffery Kim
    Lynelle Smith
    Hai Lin
    Theoretical Chemistry Accounts, 2008, 121 : 313 - 319
  • [37] Development of cytochrome P450 3A4 inhibition model.
    Arimoto, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U1019 - U1020
  • [38] QSAR modeling of in vitro inhibition of cytochrome P450 3A4*
    Mao, Boryeu
    Gozalbes, Rafael
    Barbosa, Frederique
    Migeon, Jacques
    Merrick, Sandra
    Kamm, Kelly
    Wong, Eric
    Costales, Chester
    Shi, Wei
    Wu, Cheryl
    Froloff, Nicolas
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (05) : 2125 - 2134
  • [39] Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel
    Engels, FK
    ten Tije, AJ
    Baker, SD
    Lee, CKK
    Loos, WJ
    Vulto, AG
    Verweij, J
    Sparreboom, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (05) : 448 - 454
  • [40] Antiprogestin-mediated inactivation of cytochrome P450 3A4
    Jang, GR
    Benet, LZ
    PHARMACOLOGY, 1998, 56 (03) : 150 - 157